Cell type-dependent and -independent control of HER-2/neu translation

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 1, 1999, Pages 201-213

  Child, Stephanie J ^a   Miller, Melanie K ^a   Geballe, Adam P ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Breast cancer cells; HER 2 (neu erbB 2); Translational regulation; Upstream open reading frame

Indexed keywords

MESSENGER RNA; NUCLEASE S1;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CELL TRANSFORMATION; CELL TYPE; CODON; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; NORTHERN BLOTTING; ONCOGENE NEU; OPEN READING FRAME; POLYSOME; PROGNOSIS; PROTEIN SYNTHESIS REGULATION; RNA TRANSLATION; SEQUENCE ANALYSIS;

ANIMALS; BASE SEQUENCE; CELL LINE, TRANSFORMED; CERCOPITHECUS AETHIOPS; COS CELLS; FIBROBLASTS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BIOSYNTHESIS; RECEPTOR, ERBB-2; TRANSCRIPTION, GENETIC;

EID: 0033045101     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00068-5     Document Type: Article

References (55)

1. C.I. Bargmann, M.C. Hung, R.A. Weinberg, The neu oncogene encodes an epidermal growth factor receptor-related protein, Nature 319 (1986) 226-230.
2. L. Coussens, T.L. Yang-Feng, Y.C. Liao, E. Chen, A. Gray, J. McGrath, P.H. Seeburg, T.A. Libermann, J. Schlessinger, U. Francke et al, Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene, Science 230 (1985) 1132-1139.
3. T. Yamamoto, S. Ikawa, T. Akiyama, K. Semba, N. Nomura, N. Miyajima, T. Saito, K. Toyoshima, Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor, Nature 319 (1986) 230-234.
4. A.L. Schechter, D.F. Stern, L. Vaidyanathan, S.J. Decker, J.A. Drebin, M.I. Greene, R.A. Weinberg, The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen, Nature 312 (1984) 513-516.
5. P.P. Di Fiore, J.H. Pierce, M.H. Kraus, O. Segatto, C.R. King, S.A. Aaronson, erbB-2 is a potent oncogene when overexpressed in Nih/3t3 cells, Science 237 (1987) 178-182.
6. E. Di Marco, J.H. Pierce, C.L. Knicley, P.P. Di Fiore, Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene, Molecular and Cellular Biology 10 (1990) 3247-3252.
7. R.M. Hudziak, J. Schlessinger, A. Ullrich, Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells, Proceedings of the National Academy of Sciences of the United States of America 84 (1987) 7159-7163.
8. Y. Suda, S. Aizawa, Y. Furuta, T. Yagi, Y. Ikawa, K. Saitoh, Y. Yamada, K. Toyoshima, T. Yamamoto, Induction of a variety of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659-Glu659), EMBO Journal 9 (1990) 181-190.
9. E. Liu, A. Thor, M. He, M. Barcos, B.M. Ljung, C. Benz, The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast, Oncogene 7 (1992) 1027-1032.
10. G. Pauletti, W. Godolphin, M.F. Press, D.J. Slamon, Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization, Oncogene 13 (1996) 63-72.
11. M.D. Pegram, R.S. Finn, K. Arzoo, M. Beryt, R.J. Pietras, D.J. Slamon, The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells, Oncogene 15 (1997) 537-547.
12. D.J. Slamon, G.M. Clark, S.G. Wong, W.J. Levin, A. Ullrich, W.L. McGuire, Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science 235 (1987) 177-182.
13. D.J. Slamon, W. Godolphin, L.A. Jones, J.A. Holt, S.G. Wong, D.E. Keith, W.J. Levin, S.G. Stuart, J. Udove, A. Ullrich et al, Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science 244 (1989) 707-712.
14. M.L. Disis, M.A. Cheever, HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer, Advances in Cancer Research 71 (1997) 343-371.
15. M.S. Berger, G.W. Locher, S. Saurer, W.J. Gullick, M.D. Waterfield, B. Groner, N.E. Hynes, Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading, Cancer Research 48 (1988) 1238-1243.
16. M. Guerin, M. Barrois, M.J. Terrier, M. Spielmann, G. Riou, Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis, Oncogene Research 3 (1988) 21-31.
17. M.H. Kraus, N.C. Popescu, S.C. Amsbaugh, C.R. King, Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms, EMBO Journal 6 (1987) 605-610.
18. S.J. Miller, S. T.-C., T.B. Sexton, M.-C. Hung, Mechanisms of deregulated HER2/neu expression in breast cancer cell lines, International Journal of Oncology 4 (1994) 599-608.
19. H.J. Bühring, I. Sures, B. Jallal, F.U. Weiss, F.W. Busch, W.D. Ludwig, R. Handgretinger, H.D. Waller, A. Ullrich, The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia, Blood 86 (1995) 1916-1923.
20. M. Oshima, L. Weiss, W.C. Dougall, M.I. Greene, G. Guroff, Down-regulation of c-neu receptors by nerve growth factor in PC12 cells, Journal of Neurochemistry 65 (1995) 427-433.
21. V. Band, R. Sager, Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proceedings of the National Academy of Science of the United States of America 86 (1989) 1249-1253.
22. S.A. Foster, D.A. Galloway, Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells, Oncogene 12 (1996) 1773-1779.
23. P.D. Siebert, A. Chenchik, Modified acid guanidinium thiocyanate-phenol-chloroform RNA extraction method which greatly reduces DNA contamination, Nucleic Acids Research 21 (1993) 2019-2020.
24. M.R. Schleiss, C.R. Degnin, A.P. Geballe, Translational control of human cytomegalovirus gp48 expression, Journal of Virology 65 (1991) 6782-6789.
25. J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular cloning: a laboratory manual, Cold Spring Harbor Press, Cold Spring Harbor, 1989.
26. C.R. Degnin, M.R. Schleiss, J. Cao, A.P. Geballe, Translational inhibition mediated by a short upstream open reading frame in the human cytomegalovirus gpUL4 (gp48) transcript, Journal of Virology 67 (1993) 5514-5521.
27. M. Tal, C.R. King, M.H. Kraus, A. Ullrich, J. Schlessinger, D. Givol, Human HER2 (neu) promoter: evidence for multiple mechanisms for transcriptional initiation, Molecular and Cellular Biology 7 (1987) 2597-2601.
28. B.J. Biegalke, A.P. Geballe, Sequence requirements for activation of the HIV-1 LTR by human cytomegalovirus, Virology 183 (1991) 381-385.
29. R.R. Spaete, E.S. Mocarski, Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts, Journal of Virology 56 (1985) 135-143.
30. F.L. Graham, A.J. van der Eb, A new technique for the assay of infectivity of human adenovirus 5 DNA, Virology 52 (1973) 456-467.
31. B.J. Biegalke, A.P. Geballe, Translational inhibition by cytomegalovirus transcript leaders, Virology 177 (1990) 657-667.
32. S. Ishii, F. Imamoto, Y. Yamanashi, K. Toyoshima, T. Yamamoto, Characterization of the promoter region of the human c-erbB-2 protooncogene, Proceedings of the National Academy of Sciences of the United States of America 84 (1987) 4374-4378.
33. M. Kozak, The scanning model for translation: an update, Journal of Cell Biology 108 (1989) 229-241.
34. T.C. Suen, M.C. Hung, Multiple cis- and trans-acting elements involved in regulation of the neu gene, Molecular and Cellular Biology 10 (1990) 6306-6315.
35. M.R. White, M.C. Hung, Cloning and characterization of the mouse neu promoter, Oncogene 7 (1992) 677-683.
36. A.P. Geballe, in: J.W.B. Hershey, M.B. Matthews, N. Sonenberg (Eds.), Translational control, Cold Spring Harbor Press, 1996, pp. 173-197.
37. J.W. Hershey, Translational control in mammalian cells, Annual Review of Biochemistry 60 (1991) 717-755.
38. M. Kozak, An analysis of vertebrate mRNA sequences: intimations of translational control, Journal of Cell Biology 115 (1991) 887-903.
39. J. Pelletier, N. Sonenberg, Insertion mutagenesis to increase secondary structure within the 5′ noncoding region of a eukaryotic mRNA reduces translational efficiency, Cell 40 (1985) 515-526.
40. M.C. Hung, D.H. Yan, X.Y. Zhao, Amplification of the proto-neu oncogene facilitates oncogenic activation by a single point mutation, Proceedings of the National Academy of Sciences of the United States of America 86 (1989) 2545-2548.
41. J.E. Landers, D.S. Haines, J.F. Strauss 3rd., D.L. George, Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells, Oncogene 9 (1994) 2745-2750.
42. J.E. Landers, S.L. Cassel, D.L. George, Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein, Cancer Research 57 (1997) 3562-3568.
43. H. Saya, S. Ara, P.S. Lee, J. Ro, M.C. Hung, Direct sequencing analysis of transmembrane region of human Neu gene by polymerase chain reaction, Molecular Carcinogenesis 3 (1990) 198-201.
44. A.E. Koromilas, A. Lazaris-Karatzas, N. Sonenberg, mRnas containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor eIf-4e, EMBO Journal 11 (1992) 4153-4158. Published erratum appears in EMBO J. 1992 Dec; 11(13), 5138.
45. V. Kerekatte, K. Smiley, B. Hu, A. Smith, F. Gelder, A. De Benedetti, The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas, International Journal of Cancer 64 (1995) 27-31.
46. H. Ruan, J.R. Hill, S. Fatemie-Nainie, D.R. Morris, Cell-specific translational regulation of S-adenosylmethionine decarboxylase mRNA. Influence of the structure of the 5′ transcript leader on regulation by the upstream open reading frame, Journal of Biological Chemistry 269 (1994) 17905-17910.
47. K. Reynolds, A.M. Zimmer, A. Zimmer, Regulation of RAR beta 2 mRNA expression: evidence for an inhibitory peptide encoded in the 5′-untranslated region, Journal of Cell Biology 134 (1996) 827-835.
48. J. Cao, A.P. Geballe, Mutational analysis of the translational signal in the human cytomegalovirus gpUL4 (gp48) transcript leader by retroviral infection, Virology 205 (1994) 151-160.
49. J.R. Hill, D.R. Morris, Cell-specific translation of S-adenosylmethionine decarboxylase mRNA. Regulation by the 5′ transcript leader, Journal of Biological Chemistry 267 (1992) 21886-21893.
50. J.R. Hill, D.R. Morris, Cell-specific translational regulation of S-adenosylmethionine decarboxylase mRNA. Dependence on translation and coding capacity of the cis-acting upstream open reading frame, Journal of Biological Chemistry 268 (1993) 726-731.
51. Z. Luo, M.S. Sachs, Role of an upstream open reading frame in mediating arginine-specific translational control in Neurospora crassa, Journal of Bacteriology 178 (1996) 2172-2177.
52. A.L. Parola, B.K. Kobilka, The peptide product of a 5′ leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis, Journal of Biological Chemistry 269 (1994) 4497-4505.
53. M. Werner, A. Feller, F. Messenguy, A. Pierard, The leader peptide of yeast gene CPA1 is essential for the translational repression of its expression, Cell 49 (1987) 805-813.
54. M. Kozak, Effects of intercistronic length on the efficiency of reinitiation by eucaryotic ribosomes, Molecular and Cellular Biology 7 (1987) 3438-3445.
55. K.F. Lee, H. Simon, H. Chen, B. Bates, M.C. Hung, C. Hauser, Requirement for neuregulin receptor erbB2 in neural and cardiac development [see comments], Nature 378 (1995) 394-398.